0
Prescription Medicine
₹372747
₹55912.0Cashback (15%)(Inclusive of all Taxes)
Offers & DiscountsGet Free delivery (₹99) with
Composition :
Manufacturer/Marketer :
Consume Type :
Return Policy :
About Tecentriq SC 1875 mg Injection 15 ml
Tecentriq SC 1875 mg Injection 15 ml is an anti-cancer medicine used in the treatment of unresectable, stage II-IIIa non-small cell lung cancer (NSCLC). Tecentriq SC 1875 mg Injection 15 ml is also used in combination with other cancer medicine for the treatment of metastatic NSCLC (bevacizumab, paclitaxel, carboplatin), extensive-stage small cell lung cancer and biliary tract cancer (carboplatin, etoposide), metastatic melanoma (cobimetinib, vemurafenib), and unresectable hepatocellular cancer (bevacizumab).
Tecentriq SC 1875 mg Injection 15 ml contains Atezolizumab, which belongs to the class of monoclonal antibodies. It works by inhibiting the action of a programmed death ligand receptor-1 (PD-L1), thereby stopping the abnormal growth of cancer cells.
Tecentriq SC 1875 mg Injection 15 ml may cause certain side effects such as fatigue, cough, diarrhoea, nausea, vomiting, tiredness, itching, rash, headache, fever, shortness of breath, muscle/joint pain, abdominal pain, loss of appetite and injection site reactions. Inform your doctor if any of these side effects persist for longer. Tecentriq SC 1875 mg Injection 15 ml will be administered by an oncologist trained in administering anti-cancer agents.
Avoid receiving Tecentriq SC 1875 mg Injection 15 ml and inform your doctor if you are allergic to it or any other components of it. This medicine is known to cause embryo-fetal toxicity. Hence, it is not recommended for use in pregnancy. Avoid breastfeeding while taking this Tecentriq SC 1875 mg Injection 15 ml. Before starting treatment with Tecentriq SC 1875 mg Injection 15 ml, tell your doctor if you have/had liver or kidney disease, autoimmune disorders such as ulcerative colitis or Crohn's disease, a history of organ transplants, received an allogeneic stem cell transplant, or had radiation treatment to the chest, and myasthenia gravis.
Uses of Tecentriq SC 1875 mg Injection 15 ml
Tecentriq SC 1875 mg Injection 15 ml is used in the treatment of Non-small cell lung cancer, Hepatocellular carcinoma, Biliary tract cancer, Small cell lung cancer and Metastatic melanoma. The detailed uses of Tecentriq SC 1875 mg Injection 15 ml are as follows:
Have a query?
Directions for Use
Key Benefits
Tecentriq SC 1875 mg Injection 15 ml contains Atezolizumab, which is used in the treatment of different types of cancers. It works by inhibiting the action of a programmed death ligand receptor-1 (PD-L1) that causes the multiplication of cancer cells. This helps stop the abnormal growth of cancer cells and thus reduce the further spread to other body parts.
How Tecentriq SC 1875 mg Injection 15 ml Works
Storage
What if I have taken an overdose of Tecentriq SC 1875 mg Injection 15 ml
Drug Warnings
To treat your condition effectually, continue receiving Tecentriq SC 1875 mg Injection 15 ml for the period that your doctor has prescribed. Tecentriq SC 1875 mg Injection 15 ml may cause severe immune-mediated adverse reactions (IMAR) such as immune-mediated colitis, hepatitis, hepatotoxicity, nephritis, endocrinopathies, pneumonitis, cardiac problems, and dermatologic reactions. It may also cause infusion-related reactions in some patients. Therefore, caution should be exercised if you have/had liver or kidney disease, any history of organ transplant, gastrointestinal disorders, autoimmune disorders such as ulcerative colitis or Crohn’s disease, lung disease, heart problems, and breathing difficulty while receiving Tecentriq SC 1875 mg Injection 15 ml. This medicine may also cause severe infusion-related reactions. Hence, careful monitoring is recommended and discontinue the treatment if any severe infusion reactions occur. Inform your doctor if you are pregnant or are planning to become pregnant before starting the treatment, as this medicine is known to cause embryo-fetal toxicity. Breastfeeding should be discontinued in nursing mothers during the treatment as it passes into breast milk and may cause a possible risk to the infant. This medicine is not recommended for use in children below 12 years of age as the safety and efficacy are not established.
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Alcohol
Consult your doctor
It is unknown whether Tecentriq SC 1875 mg Injection 15 ml interacts with alcohol. Consult your doctor for more information.
Pregnancy
Unsafe
Tecentriq SC 1875 mg Injection 15 ml is not recommended for use in pregnancy as it may cause embryo-fetal toxicity and harm your foetus. Hence, if you are pregnant or planning to be pregnant, inform your doctor before receiving Tecentriq SC 1875 mg Injection 15 ml. You should not become pregnant while you are receiving Tecentriq SC 1875 mg Injection 15 ml for at least five months from the last dose of Tecentriq SC 1875 mg Injection 15 ml. Using effective birth control methods while on treatment is suggested.
Breast Feeding
Unsafe
Tecentriq SC 1875 mg Injection 15 ml should not be taken if you are breastfeeding, as it passes into breast milk and may harm your infant. Avoid nursing your child while on treatment with this medicine and for at least five months from the last dose of medicine.
Driving
Caution
Tecentriq SC 1875 mg Injection 15 ml will be administered to hospitalized patients. Driving is not recommended.
Liver
Caution
If you have pre-existing or a history of liver problems, tell your doctor before receiving this medicine. Inform your doctor if you experience any symptoms, such as severe nausea or vomiting, right-sided upper stomach pain, easy bruising or bleeding, dark urine, or jaundice (yellowing of the skin or eyes). Your doctor may suggest tests to monitor your liver function while on treatment with this medicine.
Kidney
Caution
If you have a pre-existing or a history of kidney diseases, inform your doctor before receiving Tecentriq SC 1875 mg Injection 15 ml. Tell your doctor if you have little or no urination, swelling in your feet or ankles, or blood in your urine. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.
Children
Unsafe
Tecentriq SC 1875 mg Injection 15 ml is not recommended for use in children under 12 years old as the safety and efficacy are not established.
Heart
Tecentriq SC 1875 mg Injection 15 ml may cause heart-related side effects like myocarditis, pericarditis, arrhythmias, or heart failure. If you have existing heart conditions, it's essential to consult your doctor before starting treatment, as close monitoring and dose adjustments may be needed.
Geriatrics
Caution
Tecentriq SC 1875 mg Injection 15 ml can be given to geriatric patients, but older adults may face higher risks of side effects like fatigue or immune-related issues. Doctors usually assess overall health and monitor closely during treatment to ensure safety.
Tecentriq SC 1875 mg Injection 15 ml is used to treat Non-small cell lung cancer, Hepatocellular carcinoma, Biliary tract cancer, Small cell lung cancer and Metastatic melanoma.
Tecentriq SC 1875 mg Injection 15 ml contains Atezolizumab, which works by inhibiting the action of a programmed death receptor-1 (PD-L1) that causes the multiplication of cancerous cells.
Tecentriq SC 1875 mg Injection 15 ml may alter the function of your immune system and trigger an attack on healthy organs and tissues in any part of your body. These issues can occasionally worsen or even become dangerous. You can have more than one of these problems at the same time. These problems may happen anytime during your treatment or even after your treatment has ended. Therefore, please consult your doctor if you experience any changes in your body or if you have any concerns.
You should call your doctor right away if you experience any of the following severe side effects Such as chest pain, severe shortness of breath, or difficulty breathing.
Tecentriq SC 1875 mg Injection 15 ml is not recommended for use during pregnancy as it may cause embryo-fetal toxicity and harm foetus. Hence, if you are pregnant or planning to be pregnant, inform your doctor before receiving Tecentriq SC 1875 mg Injection 15 ml.
It is unknown whether Tecentriq SC 1875 mg Injection 15 ml passes into human milk. Therefore, Tecentriq SC 1875 mg Injection 15 ml is not recommended during breastfeeding and for at least 5 months after the last dose. However, if you are breastfeeding, take your doctor’s advice.
Yes, Tecentriq SC 1875 mg Injection 15 ml may affect fertility in women which may affect the ability to have children. Therefore, please inform your doctor if you have any concerns.
Yes, Tecentriq SC 1875 mg Injection 15 ml can cause hair loss (alopecia) as a side effect. This tends to resolve once treatment is stopped. However, please consult your doctor if you have any concerns.
Reduction in the size of the tumour or slowing of its growth can be a sign that the treatment is effective. Improvement in symptoms such as pain, breathing difficulties, or other cancer-related symptoms. Regular blood tests and other scans such as CT, MRI, or PET scans can show changes in tumour markers or other indicators of cancer activity.
To relieve rashes and dry, itchy skin, use a moisturizer. Wear protective clothes, stay out of direct sunlight, and use sunscreen with an SPF of at least 15. If you have a rash, avoid swimming because the chlorine in the water can worsen it. Avoid hot water baths and dress comfortably in cotton clothing. After therapy ends, your skin will usually improve.
Increase fluid intake by drinking plenty of fluids, especially water, to help soften stools. Include high-fibre foods such as whole grains, fruits, vegetables, legumes, and nuts. Engage in regular physical activity, such as walking, to help stimulate bowel movements. Limit foods and beverages that can cause gas, such as broccoli, cabbage, and carbonated drinks.
Yes, nausea and extreme tiredness (fatigue) are common side effects of Tecentriq SC 1875 mg Injection 15 ml. These symptoms occur because Tecentriq SC 1875 mg Injection 15 ml affects your immune system, which can lead to various side effects. To reduce nausea, eat smaller, more frequent meals. Stay away from oily, hot, salty, and fried foods.
Changes in taste is a common side effect of Tecentriq SC 1875 mg Injection 15 ml. To improve your taste, brush your teeth, gums, and tongue gently with a soft-bristled toothbrush and mild toothpaste. Rinse your mouth frequently with a mild solution of water, baking soda, and salt. You can also add different seasonings and flavours to find what tastes good to you.
Avoid coffee, which can cause dehydration, and foods that are fatty, fried, spicy, or excessively sweet, as these might cause nausea. Avoid smoking and alcohol consumption. Do not take any other medicines and vaccines without consulting your doctor.
The common side effects of Tecentriq SC 1875 mg Injection 15 ml are fatigue, cough, diarrhoea, nausea, vomiting, tiredness, itching, rash, headache, fever, shortness of breath, muscle/joint pain, abdominal pain, loss of appetite (hunger) and injection site reactions. If any of these side effects persist or worsen, please consult your doctor.
Country of origin
Manufacturer/Marketer address
